C. Pallier

发表

Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study

C. Charpentier, B. Masquelier, J. Izopet, 2010, Antimicrobial Agents and Chemotherapy.

Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention

J. Pawlotsky, J. Guichou, E. Hernández, 2014, Nucleic acids research.

Identification and Biochemical Characterization of Human Plasma Soluble IL-7R: Lower Concentrations in HIV-1-Infected Patients1

O. Lambotte, T. Rose, J. Delfraissy, 2009, The Journal of Immunology.

Wildo Navegantes de Araújo, M. Ziol, V. Paradis, 2019, AIDS and Behavior.

Complex dynamics of hepatitis B virus resistance to adefovir

J. Pawlotsky, P. Nordmann, C. Hézode, 2009, Hepatology.

HIV-1-Infected Patients IL-7R: Lower Concentrations in Characterization of Human Plasma Soluble Identification and Biochemical

O. Lambotte, T. Rose, J. Delfraissy, 2009 .

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)

M. Ziol, C. Delaugerre, C. Katlama, 2022, AIDS Research and Therapy.

Induction of B Cell-Activating Factor by Viral Infection Is a General Phenomenon, but the Types of Viruses and Mechanisms Depend on Cell Type

X. Mariette, P. Lebon, C. Pallier, 2010, Journal of Innate Immunity.

Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment.

P. Catalán, C. Goujard, A. Chéret, 2021, The Journal of antimicrobial chemotherapy.

Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR‐ and type‐I IFN‐dependent and ‐independent pathways

X. Mariette, J. Gottenberg, P. Lebon, 2008, European journal of immunology.

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

V. Calvez, C. Delaugerre, S. Yerly, 2017, The Journal of antimicrobial chemotherapy.

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.

V. Calvez, C. Delaugerre, S. Yerly, 2015, The Journal of antimicrobial chemotherapy.

Failure to confirm coxsackievirus infection in primary Sjögren's syndrome.

X. Mariette, P. Nordmann, J. Gottenberg, 2006, Arthritis and rheumatism.

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study

N. Schnepf, P. Colson, P. Trimoulet, 2013, Virology Journal.

Establishment of a cell line expressing human parvovirus B19 non-structural protein from an inducible promoter.

I. Vassias, F. Morinet, U. Hazan, 1997, The Journal of general virology.

Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell as demonstrated by in situ hybridization.

P. Romeo, I. Vassias, F. Morinet, 1994, The Journal of general virology.

Abbott Alinity m HR-HPV, a novel human papillomavirus assay for primary cervical cancer screening, is adapted to HPV guidelines

C. Deback, A. Roque-Afonso, S. Prévôt, 2021, Journal of Clinical Virology Plus.

Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

J. Pawlotsky, A. Boumendjel, E. Nicolle, 2011, Journal of medicinal chemistry.

Author manuscript, published in "Gastroenterology 2010;138(3):1112-22" DOI: 10.1053/j.gastro.2009.11.053 SILIBININ AND RELATED COMPOUNDS ARE DIRECT INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE

J. Pawlotsky, C. Wychowski, Ralf-Torsten Pohl, 2010 .

Herpesvirus, cytomegalovirus, human sperm and assisted fertilization.

P. Nordmann, D. Schoevaert, J. Testart, 2002, Human reproduction.

Dynamics of Hepatitis B Virus Resistance to Lamivudine

J. Pawlotsky, D. Dhumeaux, P. Nordmann, 2006, Journal of Virology.

Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study

N. Schnepf, P. Colson, P. Trimoulet, 2013, Virology Journal.

626 ULTRA-DEEP SEQUENCING ANALYSIS DEMONSTRATES PRE-EXISTENCE OF HBV RESISTANCE SUBSTITUTIONS AT BASELINE IN PATIENTS WHO SUBSEQUENTLY DEVELOP CLINICAL RESISTANCE

J. Pawlotsky, S. Chevaliez, C. Rodriguez, 2010 .

Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.

Y. Ngo, T. Poynard, V. Thibault, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Prevalence of hepatitis E virus and reassessment of HIV and other hepatitis virus seroprevalences among French prison inmates

A. Roque-Afonso, L. Izquierdo, C. Pallier, 2019, PloS one.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study

V. Calvez, C. Charpentier, C. Delaugerre, 2017, The Journal of antimicrobial chemotherapy.

Dolutegravir Cerebrospinal Fluid Diffusion in HIV-1–Infected Patients with Central Nervous System Impairment

C. Goujard, A. Chéret, V. Furlan, 2019, Open forum infectious diseases.

The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells

I. Vassias, A. Greco, F. Morinet, 1997, Journal of virology.

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Resting Regulatory CD4 T Cells: A Site of HIV Persistence in Patients on Long-Term Effective Antiretroviral Therapy

C. Goujard, J. Delfraissy, T. Tran, 2008, PloS one.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns.

D. Roulot, O. Lortholary, J. Stirnemann, 2001, The Journal of general virology.

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2013, The Journal of antimicrobial chemotherapy.

Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins

F. Morinet, M. Leruez-Ville, M. Deplanche, 1996, Clinical and diagnostic laboratory immunology.

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2010, The Journal of antimicrobial chemotherapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).

M. Ziol, V. Paradis, C. Delaugerre, 2020, Journal of hepatology.

Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes.

P. Nordmann, V. Maréchal, M. Bianchi, 2003, Molecular biology of the cell.

Reliability, cost-effectiveness, and safety of reuse of ancillary devices for ERCP.

F. Prat, P. Nordmann, G. Pelletier, 2004, Gastrointestinal endoscopy.

[Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses].

C. Pallier, 2005, Virologie.

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Targeted HIV Screening in Eight Emergency Departments: The DICI‐VIH Cluster‐Randomized Two‐Period Crossover Trial

G. Verbeke, I. Durand-zaleski, G. Hejblum, 2017, Annals of emergency medicine.

Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples.

C. Prégermain, A. Roque-Afonso, C. Pallier, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2018, The Journal of antimicrobial chemotherapy.

Comparison of serum and plasma viral load measurements in human immunodeficiency virus type 1 infection

A. Roque-Afonso, C. Pallier, Lina Mouna, 2023, Journal of Clinical Virology Plus.

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

V. Calvez, C. Charpentier, P. Bellecave, 2021, The Journal of antimicrobial chemotherapy.

Identification and Biochemical Characterization of Human Plasma Soluble IL-7R: Lower Concentrations in HIV-1-Infected Patients

O. Lambotte, T. Rose, J. Delfraissy, 2009 .

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

V. Calvez, C. Charpentier, J. Izopet, 2019, The Journal of antimicrobial chemotherapy.

OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE

J. Pawlotsky, A. Ahmed-Belkacem, C. Pallier, 2010 .

New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017

V. Calvez, P. Bellecave, D. Descamps, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin

C. Louapre, C. Lubetzki, E. Maillart, 2018, Multiple sclerosis.

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

[55] COMPLEX DYNAMICS OF HEPATITIS B VIRUS RESISTANCE TO ADEFOVIR DIPIVOXIL

J. Pawlotsky, C. Hézode, C. Rodriguez, 2007 .

[Disseminated varicella-zoster virus infection with hemorrhagic gastritis during the course of chronic lymphocytic leukemia: case report and literature review].

F. Carbonnel, O. Lambotte, J. Michot, 2014, La Revue de medecine interne.

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.